| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8790697 | American Journal of Ophthalmology | 2018 | 21 Pages |
Abstract
The diagnosis and management of ROP has changed over the past 40 years; the role of anti-VEGF therapy remains to be established in current treatment strategies. Screening for initial disease and progression will likely be impacted by the increasing prevalence of telemedicine and relative shortage of clinicians.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Paul Jr., Alia K. Durrani,